EP Patent

EP2360139A2 — Ferric organic compounds, uses thereof and methods of making same

Assigned to Panion and BF Biotech Inc · Expires 2011-08-24 · 15y expired

What this patent protects

The present invention is directed to forms of ferric organic compounds, uses thereof, and methods of making same. The present invention discloses a novel physical form of ferric citrate with dissolution properties desirable for use in medicine, including the treatment of hyperpho…

USPTO Abstract

The present invention is directed to forms of ferric organic compounds, uses thereof, and methods of making same. The present invention discloses a novel physical form of ferric citrate with dissolution properties desirable for use in medicine, including the treatment of hyperphosphatemia and metabolic acidosis.

Drugs covered by this patent

Patent Metadata

Patent number
EP2360139A2
Jurisdiction
EP
Classification
—
Expires
2011-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Panion and BF Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.